BG61913B1 - 1-арилциклоалкилови сулфиди, сулфоксиди и сулфони за лечениена депресии, страхова невроза и болестта на паркинсон - Google Patents
1-арилциклоалкилови сулфиди, сулфоксиди и сулфони за лечениена депресии, страхова невроза и болестта на паркинсон Download PDFInfo
- Publication number
- BG61913B1 BG61913B1 BG100127A BG10012795A BG61913B1 BG 61913 B1 BG61913 B1 BG 61913B1 BG 100127 A BG100127 A BG 100127A BG 10012795 A BG10012795 A BG 10012795A BG 61913 B1 BG61913 B1 BG 61913B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- formula
- carbon atoms
- cyclobutyl
- dichlorophenyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939309749A GB9309749D0 (en) | 1993-05-12 | 1993-05-12 | Therapeutic agents |
| PCT/EP1994/001494 WO1994026704A1 (en) | 1993-05-12 | 1994-05-07 | 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG100127A BG100127A (bg) | 1996-07-31 |
| BG61913B1 true BG61913B1 (bg) | 1998-09-30 |
Family
ID=10735317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG100127A BG61913B1 (bg) | 1993-05-12 | 1995-11-10 | 1-арилциклоалкилови сулфиди, сулфоксиди и сулфони за лечениена депресии, страхова невроза и болестта на паркинсон |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5652271A (de) |
| EP (1) | EP0715620B1 (de) |
| JP (2) | JP3606326B2 (de) |
| KR (1) | KR100295264B1 (de) |
| AT (1) | ATE172719T1 (de) |
| AU (1) | AU681669B2 (de) |
| BG (1) | BG61913B1 (de) |
| BR (2) | BR9406577A (de) |
| CZ (1) | CZ290711B6 (de) |
| DE (1) | DE69414264T2 (de) |
| DK (1) | DK0715620T3 (de) |
| ES (1) | ES2124411T3 (de) |
| FI (1) | FI955429A (de) |
| GB (1) | GB9309749D0 (de) |
| HU (1) | HU211124A9 (de) |
| IL (1) | IL109635A (de) |
| LV (1) | LV11320A (de) |
| MY (1) | MY110773A (de) |
| NO (1) | NO305165B1 (de) |
| NZ (1) | NZ266776A (de) |
| PH (1) | PH30418A (de) |
| PL (1) | PL176400B1 (de) |
| RO (1) | RO115519B1 (de) |
| RU (1) | RU2135467C1 (de) |
| SK (1) | SK281257B6 (de) |
| TW (1) | TW318833B (de) |
| UA (1) | UA42722C2 (de) |
| WO (1) | WO1994026704A1 (de) |
| ZA (1) | ZA943241B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19518988A1 (de) * | 1995-05-29 | 1996-12-05 | Basf Ag | Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit |
| GB9524681D0 (en) | 1995-12-02 | 1996-01-31 | Knoll Ag | Chemical process |
| GB9915617D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| US20030224045A1 (en) * | 2002-05-29 | 2003-12-04 | Chien-Hsuan Han | Combination immediate release sustained release levodopa/carbidopa dosage forms |
| US20060013875A1 (en) * | 2002-05-29 | 2006-01-19 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
| US20040166159A1 (en) * | 2002-05-29 | 2004-08-26 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa |
| US7094427B2 (en) * | 2002-05-29 | 2006-08-22 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
| MX2008013728A (es) * | 2006-04-26 | 2009-01-07 | Toyama Chemical Co Ltd | Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo. |
| EP3054929B1 (de) | 2013-10-07 | 2020-08-05 | Impax Laboratories, LLC | Mukoadhäsive levodopa-formulierungen mit gesteuerter freisetzung und/oder levodopa-ester und verwendungen davon |
| US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
| US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52768B1 (en) * | 1981-04-06 | 1988-02-17 | Boots Co Ltd | 1-arylcyclobutylalkylamine compounds useful as therapeutic agents |
| IE56000B1 (en) * | 1982-09-30 | 1991-03-13 | Boots Co Plc | 1-arylcyclobutylalkylamine compounds |
| GB8501192D0 (en) * | 1985-01-17 | 1985-02-20 | Boots Co Plc | Therapeutic agents |
| GB8704777D0 (en) * | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
-
1993
- 1993-05-12 GB GB939309749A patent/GB9309749D0/en active Pending
-
1994
- 1994-05-07 EP EP94916944A patent/EP0715620B1/de not_active Expired - Lifetime
- 1994-05-07 JP JP52494694A patent/JP3606326B2/ja not_active Expired - Lifetime
- 1994-05-07 RO RO95-01958A patent/RO115519B1/ro unknown
- 1994-05-07 ES ES94916944T patent/ES2124411T3/es not_active Expired - Lifetime
- 1994-05-07 SK SK1407-95A patent/SK281257B6/sk not_active IP Right Cessation
- 1994-05-07 DK DK94916944T patent/DK0715620T3/da active
- 1994-05-07 BR BR9406577A patent/BR9406577A/pt not_active Application Discontinuation
- 1994-05-07 AU AU68433/94A patent/AU681669B2/en not_active Expired
- 1994-05-07 KR KR1019950705037A patent/KR100295264B1/ko not_active IP Right Cessation
- 1994-05-07 WO PCT/EP1994/001494 patent/WO1994026704A1/en active IP Right Grant
- 1994-05-07 CZ CZ19952936A patent/CZ290711B6/cs not_active IP Right Cessation
- 1994-05-07 PL PL94311628A patent/PL176400B1/pl unknown
- 1994-05-07 AT AT94916944T patent/ATE172719T1/de active
- 1994-05-07 RU RU95122740A patent/RU2135467C1/ru active
- 1994-05-07 DE DE69414264T patent/DE69414264T2/de not_active Expired - Lifetime
- 1994-05-07 UA UA95114926A patent/UA42722C2/uk unknown
- 1994-05-07 NZ NZ266776A patent/NZ266776A/en not_active IP Right Cessation
- 1994-05-07 US US08/545,752 patent/US5652271A/en not_active Expired - Lifetime
- 1994-05-11 ZA ZA943241A patent/ZA943241B/xx unknown
- 1994-05-12 PH PH48262A patent/PH30418A/en unknown
- 1994-05-12 IL IL109635A patent/IL109635A/en not_active IP Right Cessation
- 1994-05-12 MY MYPI94001186A patent/MY110773A/en unknown
- 1994-11-11 TW TW083110470A patent/TW318833B/zh active
-
1995
- 1995-06-30 HU HU95P/P00686P patent/HU211124A9/hu unknown
- 1995-11-10 FI FI955429A patent/FI955429A/fi unknown
- 1995-11-10 BG BG100127A patent/BG61913B1/bg unknown
- 1995-11-10 NO NO954542A patent/NO305165B1/no not_active IP Right Cessation
- 1995-12-11 LV LV950366A patent/LV11320A/xx unknown
-
1997
- 1997-04-22 BR BR1100306-5A patent/BR1100306A/pt active IP Right Grant
-
2004
- 2004-06-16 JP JP2004178477A patent/JP2004331669A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6136803A (en) | Antidepressants | |
| US5580866A (en) | Therapeutic 1,4-thiazepines | |
| CS216544B2 (en) | Method of preparation of basic ethers | |
| EP0047536B1 (de) | Substituierte Propylamine | |
| BG61913B1 (bg) | 1-арилциклоалкилови сулфиди, сулфоксиди и сулфони за лечениена депресии, страхова невроза и болестта на паркинсон | |
| EP0237573A1 (de) | Neue benzothiazinabkömmlinge | |
| PL90695B1 (de) | ||
| US5910586A (en) | Tricyclic aminoalkylcarboxamides; dopamine D3 receptor subtype specific ligands | |
| PL90025B1 (de) | ||
| IE61901B1 (en) | "Substituted 1h-imidazoles" | |
| CA1069506A (en) | Dibenzo (b,f) thiepin derivative | |
| US4237311A (en) | 2-Methyl-1-(substituted)phenyl-2-propyl esters of 2-aminopropanoic acid | |
| CZ127293A3 (en) | Biphenylquinuclidines, process of their preparation and pharmaceutical preparations in which they are comprised | |
| HU178147B (en) | Process for producing hexahydro-1,4-oxazepines | |
| CA2162706C (en) | 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease | |
| JPS625982A (ja) | チアゾリジン誘導体 | |
| JPH068284B2 (ja) | ３−チオキソ−ベンゾチアジン誘導体 | |
| JP4152002B2 (ja) | ２−フェニルモルホリン−５−オン誘導体およびそれを含む医薬組成物 | |
| US4054654A (en) | Isoindolin-1-one derivatives | |
| US5610161A (en) | Therapeutic agents | |
| GB2197315A (en) | Anti-anxiety propanolamine derivatives | |
| JPH0551588B2 (de) | ||
| JPS63115858A (ja) | 医薬組成物 |